fda approved glp-1 receptor agonists Pharmacovigilance Assessment of Compounded Agonists: Insights From the Adverse Event Reporting System Do GLP-1 Patches Really Work?
Description
Our previous work has shown that GLP-1 RAs make up 5% of prescriptions within the US (although this trend has increased, as seen in the latest GLP-1 prescribing and dispense report)
Safety analysis showed no increased risk of infections (SGLT2i) or pancreatitis (GLP-1RAs)
Furthermore, in an internet survey of former statin users, 60% reported SAMSs, and 62% reported discontinuation of statin due to side effects [78]
A study that would be very challenging to run (controlled fixed diet - with and without GLP1)
